Remember me
ORIGINAL ARTICLE
Year : 2021 | Volume
: 23
| Issue : 2 | Page : 197-204
A novel homozygous frameshift mutation in MNS1 associated with severe oligoasthenoteratozoospermia in humans
Yong Li1, Wei-Li Wang1, Chao-Feng Tu1,2,3, Lan-Lan Meng2,3, Tong-Yao Hu1, Juan Du1,2,3, Ge Lin1,2,3, Hong-Chuan Nie1,2,3, Yue-Qiu Tan1,2,3
1 Institute of Reproductive and Stem Cell Engineering, School of Basic Medical Science, Central South University, Changsha 410078, China
2 Reproductive and Genetic Hospital of CITIC-Xiangya, Changsha 410078, China
3 Clinical Research Center for Reproduction and Genetics in Hunan Province, Changsha 410078, China
Correspondence Address:
Hong-Chuan Nie
Institute of Reproductive and Stem Cell Engineering, School of Basic Medical Science, Central South University, Changsha 410078, China; Reproductive and Genetic Hospital of CITIC-Xiangya, Changsha 410078, China; Clinical Research Center for Reproduction and Genetics in Hunan Province, Changsha 410078, China
Yue-Qiu Tan
Institute of Reproductive and Stem Cell Engineering, School of Basic Medical Science, Central South University, Changsha 410078, China; Reproductive and Genetic Hospital of CITIC-Xiangya, Changsha 410078, China; Clinical Research Center for Reproduction and Genetics in Hunan Province, Changsha 410078, China
Source of Support: None, Conflict of Interest: None
Check
1DOI: 10.4103/aja.aja_56_20
Oligoasthenoteratozoospermia (OAT) refers to the combination of various sperm abnormalities, including a decreased sperm count, reduced motility, and abnormal sperm morphology. Only a few genetic causes have been shown to be associated with OAT. Herein, we identified a novel homozygous frameshift mutation in meiosis-specific nuclear structural 1 (MNS1; NM_018365: c.603_604insG: p.Lys202Glufs*6) by whole-exome sequencing in an OAT proband from a consanguineous Chinese family. Subsequent variant screening identified four additional heterozygous MNS1 variants in 6/219 infertile individuals with oligoasthenospermia, but no MNS1 variants were observed among 223 fertile controls. Immunostaining analysis showed MNS1 to be normally located in the whole-sperm flagella, but was absent in the proband's sperm. Expression analysis by Western blot also confirmed that MNS1 was absent in the proband's sperm. Abnormal flagellum morphology and ultrastructural disturbances in outer doublet microtubules were observed in the proband's sperm. A total of three intracytoplasmic sperm injection cycles were carried out for the proband's wife, but they all failed to lead to a successful pregnancy. Overall, this is the first study to report a loss-of-function mutation in MNS1 causing OAT in a Han Chinese patient.
Keywords: intracytoplasmic sperm injection; male infertility; meiosis-specific nuclear structural 1 (MNS1) ; oligoasthenoteratozoospermia; whole-exome sequencing
Yong Li, Wei-Li Wang
These authors contributed equally to this work.
Infertility is a significant global health issue that affects approximately 15% of couples, with male factors and female factors contributing equally.[1] Infertile men frequently exhibit sperm abnormalities, which could be identified through conventional semen analysis. According to the World Health Organization (WHO) guidelines,[2] semen analysis may show decreased sperm count (oligozoospermia, the sperm count <15 × 10[6] ml−1), poor motility (asthenozoospermia, progressive sperm <32%), and abnormal sperm morphology (teratozoospermia, amount of morphologically normal sperm <4%). The combination of these abnormalities is termed oligoasthenoteratozoospermia (OAT),[3] and idiopathic OAT (iOAT) is responsible for approximately 30% of all cases of male infertility.[4] Recently, a specific kind of asthenoteratozoospermia, the multiple morphological abnormalities of the sperm flagella (MMAF), has been identified and is characterized by various flagellar morphological abnormalities (absent, short, bent, coiled, and irregular flagella).[5]
The etiology of male infertility is extremely complicated, and the causes remain largely unknown.[6] It is currently thought that genetic defects account for at least 15% of all male infertility cases.[7] More than 2300 genes have been predicted to be involved in spermatogenesis,[8] but causal mutations have only been identified in a small number of genes in humans. To date, only a few genes associated with OAT have been identified including FA complementation group M (FANCM),[9] dynein axonemal heavy chain 1 (DNAH1),[5] and cilia- and flagella-associated protein 44 (CFAP44)[9],[10] in humans and acetylgalactosaminyltransferase 3 (Galnt3),[11] CCR4-NOT transcription complex subunit 7 (Cnot7),[12] HIV-1 rev-binding protein (Hrb),[13] cell adhesion molecule 1 (Cadm1/Ra175),[14] and oxysterol-binding protein-related protein 4 (Orp4)[15] in mice. The majority of genetic causes and associated mechanisms of OAT in humans still remain unclear.
MNS1, meiosis-specific nuclear structural 1, is located at 15q21.3 in humans and has 10 exons encoding a 495-amino acid protein, which has been identified in human bronchial epithelium.[16]Mns1 was found to be essential for sperm tail development in mice, and Mns1-knockout (KO) mice present with male infertility due to OAT.[17] In humans, three homozygous loss-of-function mutations in MNS1 from two unrelated groups have been reported to potentially cause laterality defects and male infertility.[18],[19] However, the explicit infertility phenotype caused by mutations in MNS1 is poorly understood.
In this study, we performed whole-exome sequencing (WES) in an idiopathic infertile male with severe OAT from a consanguineous family. A homozygous loss-of-function mutation in MNS1 was identified and functionally characterized using the patient's spermatozoa. This is the first report of an MNS1 mutation associated with OAT in a Chinese patient.
Patients and MethodsPatients
The proband (family member IV-1, 34 years old) with primary infertility from a consanguineous Han Chinese family (Changde, China) visited the Reproductive and Genetic Hospital of CITIC-Xiangya for genetic counseling of infertility treatment. Although the couple had been married for 7 years, his wife failed to conceive in the absence of contraception. The proband's wife (33 years old) did not show any abnormities upon routine clinical examination before intracytoplasmic sperm injection (ICSI) treatment. The proband's parents (III-1 and III-2) were first-degree cousins from Hunan province. In addition, the proband's brother (IV-2) is fertile and his wife gave birth to a child through normal delivery. Written informed consent was obtained from all the participants in this study. This study was approved by the Ethics Committee (Changsha, China) of the Reproductive and Genetic Hospital of CITIC-Xiangya and Central South University (LL-SC-2017-025).
Whole-exome sequencing
Peripheral blood samples of the family members (III-1, III-2, IV-1, and IV-2) were collected. Genomic DNA samples from peripheral blood were extracted using a QIAamp DNA Blood Midi Kit (Qiagen, Hilden, Germany). The proband (IV-1) was subjected to WES using the HiSeq 2000 sequencing platform (Illumina, San Diego, CA, USA) at the Beijing Genome Institute in Shenzhen. Agilent SureSelect Human All Exon v6 Kit (Agilent, Santa Clara, CA, USA) was used for the capture of known exons and exon–intron boundary sequences. The detailed procedure of WES and the data analysis conducted have been described previously.[20]
Bioinformatics and in silico analysis of the candidate variant
The putative gene pathogenic variants that matched the following criteria were considered: (1) allele frequencies below 5% in the following databases (dbSNP, 1000 Genomes Project, ExAC); (2) the variations were predicted to be deleterious using four different tools: polyphen-2 (http://genetics.bwh.harvard.edu/pph2), SIFT (http://sift.bii.a-star.edu.sg/), Mutation Taster (http://www.mutationtaster.org/), and Combined Annotation-Dependent Depletion (CADD; cadd.gs.washington.edu/); (3) highly expressed in testes; and (4) associated with fertility. Homozygosity mapping was performed using HomozygosityMapper,[21] and homozygous variants located in homozygous regions >2.0 Mb were prioritized. For in silico analysis, evolutionary conservation analysis was performed through alignment of the amino acid sequences of the proteins between different species from the GenBank database (https://www.ncbi.nlm.nih.gov/homologene/). The protein structure was predicted using the simple modular architecture research tool (SMART) database (http://smart.embl-heidelberg.de/).
Sanger sequencing
The candidate variant of MNS1 was validated by Sanger sequencing using specific primers flanking the variant of the candidate gene, MNS1-F: 5'-GAAACGTGATGCTGAAATAGCC-3' and MNS1-R: 5'-AGTTCCTCACAACAAACCTGTGATA-3'. The variant site in MNS1 was amplified through polymerase chain reaction (PCR) using Ex Taq DNA polymerase (Bio-Rad, Hercules, CA, USA) for all the family members. All the PCR products were sequenced using the ABI 3730 automated sequencer (Applied Biosystems, Foster City, CA, USA) according to the manufacturer's instructions.
Hematoxylin and eosin (H&E) staining and immunostaining
To obtain the sperm smears, sperm from the proband and the fertile control individual were washed using a saline solution, centrifuged, smeared, and fixed in 4% paraformaldehyde (PFA). In order to visualize the morphological features of sperm, sperm smears were stained with H&E. Immunostaining of the slides was performed as described previously.[22] Sperm smears were incubated with primary antibodies: MNS1, A-kinase anchoring protein 4 (AKAP4, a fibrous sheath marker),[23] translocase of outer mitochondrial membrane 20 (TOMM20, a mitochondrial sheath marker),[24] dynein axonemal intermediate chain 1 (DNAI1, an outer dynein arms marker),[25],[26] dynein axonemal light intermediate chain 1 (DNALI1, an inner dynein arms marker),[27] and anti-acetylated tubulin monoclonal antibody for 2 h at 37°C. The details of the antibodies are listed in [Supplementary Table 1]. The binding of the antibodies was detected by incubating with Alexa Fluor 488 anti-mouse IgG (A-21121; Invitrogen, Carlsbad, CA, USA; 1:400) and Alexa Fluor 555 anti-rabbit IgG (A31572; Invitrogen; 1:400) for 1 h at 37°C. Subsequently, the sperm smears were stained with 4',6-diamidino-2-phenylindole (DAPI) for 5 min. Finally, they were viewed using an Olympus BX-51 fluorescence microscope (Olympus, Tokyo, Japan).
Transmission electron microscopy (TEM)
Sperm of the proband and the fertile control individual were fixed overnight in 2.5% glutaraldehyde (Sigma-Aldrich, Saint Louis, MO, USA) in 0.1 mol l−1 phosphate buffer (pH 7.4), and then in 1.0% osmium tetroxide (OsO4, HalingBio, Shanghai, China) for 2 h. They were immediately subjected to postfixation processing with 1% OsO4 and 0.1 mol l−1 sucrose in 0.1 mol l−1 phosphate buffer; subsequently dehydrated with graded concentrations of ethanol; and thereafter embedded in Epon812, dodecenylsuccinic anhydride, methylnadic anhydride, and dimethylaminomethyl phenol (EMS, Hatfield, PA, USA) at 60°C for 24 h. Semithin 1-μm-thick sections were stained with toluidine blue (Solarbio, Beijing, China) for light microscopy (Olympus). Ultrathin 80 nm-thick sections were contrasted with uranyl acetate (Chemos, Altdorf, Germany) and lead citrate (Chemos) and examined using a H7700 Hitachi electron microscope (Hitachi, Tokyo, Japan). Digital images were captured using a MegaView III digital camera (MegaView, Munster, Germany).
Western blot
Western blot analysis of proteins in the sperm was performed as described previously.[22] Briefly, proteins of the proband and control individual were blotted onto a polyvinylidene difluoride membrane and incubated overnight at 4°C with anti-MNS1 antibody (Sigma-Aldrich, HPA039975). The samples were then incubated with goat anti-rabbit IgG-horseradish peroxidase-conjugated secondary antibodies (GAR007-100, Multi Sciences, Hangzhou, China) and visualized by enhanced chemiluminescence (Pierced, Grand Island, NY, USA). Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used as the control.
Population screening for MNS1 variants
Peripheral blood genomic DNA samples were collected from 219 infertile individuals with oligoasthenospermia and 223 fertile controls who had normal fertility and at least one live offspring via natural fertilization. All the infertile individuals and the fertile controls were of Han Chinese origin. Following WHO guidelines (2010),[28] semen volume, sperm count, sperm progressive motility, and proportion of normal morphology of all the infertile individuals and the fertile controls were evaluated [Table 1]. All the DNA samples were subjected to WES and Sanger sequencing as previously described[29] [Supplementary Table 2]. Neither abnormal somatic karyotypes nor Y chromosome microdeletions were detected.
Table 1: Semen analysis and intracytoplasmic sperm injection treatment of the proband IV-1 and screened individuals Results Clinical characterization of the proband
The proband (IV-1) was 34 years old and from a consanguineous family [Figure 1]a. The semen examination results of the proband were as follows: semen volume, 3.4 ml; sperm concentration, 1.8 × 10[6] ml−1; and percentage progressive motility, 5.8%. Semen analysis revealed the normal sperm morphology to be 2.6% [Table 1]. Collectively, these results led to the diagnosis of severe OAT. Physical examination results of the proband showed normal testicular size, external genital development, and bilateral spermatic vein. The chromosomal karyotype of the proband was 46, XY; no Y chromosome microdeletions were found. According to previous medical records of the proband, he had no history of respiratory disorders, situs inversus, exposure to hazardous environments, or poor habits such as smoking and drinking.
Figure 1: Pedigree of the family and analyses of MNS1 in the consanguineous Chinese family. (a) The pedigree of the consanguineous Chinese family with inherited MNS1 pathogenic variant. The proband in these families is indicated as “P” plus a black arrow. A dot in the middle of the symbol indicates heterozygous carriers. Sanger sequencing confirmation of MNS1 variant c.603_604insG in this family; the unaffected parents and the proband's brother are heterozygous carriers of the variation of MNS1, c.603_604insG, whereas the proband is homozygous for the variation. (b) Homozygosity mapping of the proband. Homozygous regions with remarkable signal are indicated in red. The asterisk indicates the area where MNS1 is located. P: proband; MNS1: meiosis-specific nuclear structural 1.Identification of the MNS1 variant
WES was performed to determine the genetic causes of OAT in the proband. To identify likely pathogenic variants, those that occurred with a frequency of >5% in three public databases and predicted not to be deleterious were excluded; for patients from a consanguineous family, homozygous variants with known roles associated with the observed infertility phenotype or homozygous region larger than 2.0 Mb were prioritized. After screening, only one novel homozygous frameshift variant (NM_018365: exon5: c.603_604insG: p. Lys202Glufs*6) in MNS1 was found to fulfill these criteria [Figure 1]b and [Table 2]. However, this variant was absent in public databases [Table 2]. Subsequent Sanger sequencing and co-segregation analysis confirmed that the proband was homozygous for the variant, whereas the unaffected proband's parents and brother were heterozygous carriers [Figure 1]a. The gene variant co-segregated with the OAT phenotype in the family and is also consistent with the autosomal recessive mode of inheritance. No apparent deleterious biallelic variants in MNS1 were found in 219 infertile individuals with oligoasthenospermia and 223 fertile controls from the Han Chinese population. Although four MNS1 heterozygous variants in six infertile individuals with oligoasthenospermia (none in the fertile control; [Table 2] and [Supplementary Figure 1]a were identified, they were unlikely to be the cause of infertility for these infertile individuals. Thus, other candidate variants in other genes should be investigated in future.
Table 2: Information for the identified MNS1 variants in the proband IV-1 and screened subjectsThe impact of MNS1 variant
Evolutionary conservation analysis showed that the amino acid (lysine 202) in human MNS1 is highly conserved among different species [Figure 2]a, revealing the functional importance of the lysine 202 site. The frameshift variant occurred in the fifth exon [Figure 2]b and was predicted to result in a premature termination codon (PTC) at site 207. The PTC could involve nonsense-mediated mRNA decay (NMD), leading to the absence of MNS1 protein or generation of a truncated protein (206 amino acids), which might maintain partial functionality or totally degrade due to instability.
Figure 2: The impact of the MNS1 variant. (a) Evolutionary conservation analysis of the MNS1 variant among different species. (b) The positions of the identified variant (red) and previously reported mutations (black) in MNS1 in patients are shown. The trichohyalin–plectin–homology (TPH) domain (http://smart.embl-heidelberg.de/) in MNS1 is indicated in blue. (c) Western blot analysis shows that the MNS1 protein (approximately 60 kDa) is absent from the proband's sperm. (d) Immunostaining analysis shows that MNS1 is localized in the flagella of the sperm in the NC, but was absent in the sperm of the proband (IV-1; n = 120). In the NC, the staining of MNS1 in the midpiece is prominent, whereas that in the principal and end piece is distributed discretely with distinct dots. Scale bars = 5 μm. MNS1: meiosis-specific nuclear structural 1; α-tub: alpha-tubulin; GAPDH: glyceraldehyde 3-phosphate dehydrogenase; NC: normal control.To identify the exact impact of the MNS1 frameshift variant, we explored the expression of MNS1 in the proband. Western blot analysis was performed for the sperm proteins using the C-terminus antibody (binding 368–488 aa). The fertile control showed a band of MNS1 at approximately 60 kDa, but the same was absent in the proband's sperm [Figure 2]c. Because the mutated transcript is almost certainly a substrate for NMD, it is probable that MNS1 was absent from the flagella in the proband. Immunostaining also showed that MNS1 was located in the whole-length sperm flagella of the control individual, but was absent in the proband's sperm (n = 120; [Figure 2]d and [Supplementary Figure 2]a. Collectively, these results strongly suggest that the MNS1 frameshift mutation is the cause of OAT in the proband.
Sperm morphology and structural defects
H&E staining and TEM were performed to reveal the abnormalities of sperm morphology and ultrastructure. Although there were also some spermatozoa with seemingly normal morphology, H&E staining showed that there were morphological abnormalities in the proband's sperm, including absent, bent, coiled, and short flagella, compared to the control individual [Figure 3]a. The absent, bent, coiled, and short flagella, respectively, accounted for 15.0%, 20.0%, 29.2%, and 32.5% in the proband's sperm (n = 120; [Table 3]. TEM showed ultrastructural defects in the proband's sperm, with frequent absence of outer doublet microtubules (DMT, 7 + 2, 6 + 2, or 5 + 2, accounting for 40%), and sporadic absence of the central complex (6 + 0 or 9 + 0, accounting for 8%) in 50% (n = 50) of the cross-sections, compared to the normal control [Figure 3]b. To further determine abnormalities in the axonemal or peri-axonemal structures of the sperm flagella in the proband, immunostaining was performed. For each marker, ≥100 sperm were analyzed for both the proband and the normal control. In the proband's spermatozoa, the staining signal of the outer dynein arms (ODA; DNAI1)[25],[26] was undetectable compared to the normal control [Figure 3]c and [Supplementary Figure 2]b, indicating that MNS1 mutation induced a loss of ODAs in the sperm. Moreover, the expression and location of markers of fibrous sheath (FS; AKAP4; [Supplementary Figure 1]b,[23] mitochondrial sheath (MS; TOMM20; [Supplementary Figure 1]c,[24] and inner dynein arms (IDA; DNALI1; [Supplementary Figure 1]d[27] revealed no abnormalities. Taken together, these results indicate that defective MNS1 may impair the assembly of DMTs and ODAs during flagellar formation in humans.
Figure 3: The morphological and structural abnormalities in the proband with MNS1 mutation. (a) H&E staining shows that there were many morphological abnormalities in the proband's sperm, including absent, bent, coiled, and short flagella, compared to the NC. Scale bars = 10 μm. A histogram summary of the sperm morphology is shown on the right. (b) Transmission electron micrographs show subtle ultrastructural defects in the proband's sperm, with the absence of outer doublet microtubules or central pair complex of the cross-sections, compared to NC samples. A red asterisk shows the absence of central pair complex. Scale bars = 100 nm. A histogram summary of the ultrastructural defects is shown in the right. (c) Immunofluorescence shows the expression and location of DNAI1 (a marker for outer dynein arm). Compared to NC, DNAI1 staining appears absent from the sperm flagella in the proband (n = 120). Scale bars = 5 μm. MNS1: meiosis-specific nuclear structural 1; α-tub: alpha-tubulin; GAPDH: glyceraldehyde 3-phosphate dehydrogenase; NC: normal control; H&E: hematoxylin and eosin.Intracytoplasmic sperm injection (ICSI) and pregnancy outcome
The couple had undergone two ICSI cycles at another hospital in 2014. However, the first transplant failed due to implantation failure, and the second result was an ectopic pregnancy. His wife underwent laparoscopic surgery following the ectopic pregnancy to clear ovarian lesions. In 2017, it was discovered that she had endometrial polypoid hyperplasia and bilateral polycystic ovarian changes. At our hospital, 11 eggs were collected from the proband's wife in 2018, ten of which were MII oocytes and were used for ICSI with the spermatozoa of the proband. Then, eight eggs were fertilized successfully (fertilization rate: 80%), and eight viable cleavage embryos were achieved, which suggests that normal embryos could be obtained using the spermatozoa with the MNS1 mutation during ICSI treatment. Finally, two frozen embryos were transplanted; however, the proband's wife still failed to conceive after transplantation [Table 1].
DiscussionIn this study, we identified a novel homozygous frameshift mutation in MNS1 in a patient with severe OAT. Subsequent analysis showed morphological abnormalities in flagella and ultrastructural disturbances of axoneme in the proband's spermatozoa. MNS1 is normally located at the whole-length sperm flagella, but was almost completely absent in the proband's sperm. Overall, our study showed that loss of function of MNS1 was responsible for the OAT phenotype of this proband and MNS1 may play an important role during spermatogenesis.
MNS1 encodes a 495-amino acid protein, which includes the trichohyalin–plectin–homology (TPH) domain (https://smart.embl.de/smart) and five coiled-coils (http://www.ebi.ac.uk/interpro). The localization and function of MNS1 in spermatogenesis is poorly understood. During spermiogenesis, MNS1 is known to be a KIF3A-mediated cargo protein transiently transported (a motor protein) to the manchette,[30] which is a transient microtubular structure with an essential role in the transport/assembly of peri-axonemal structures. Moreover, sodium dodecyl sulfate treatment of caudal epididymal sperm indicated that MNS1 may exist in the detergent-resistant flagellar structures (peri-axoneme structures) of the sperm flagella.[17] MNS1 has also been shown to interact with a mitochondrial fusion protein, mitofusin 2 (MFN2).[31] In our study, we identified that MNS1 is localized to not only the mid and principal piece, but also the endpiece (eliminated of any peri-axonemal structures) of sperm flagella. Thus, we speculated that full-length MNS1 may also play a role in the axoneme in addition to that in the peri-axoneme of sperm flagella.
MNS1 has been shown to function in other motile cilia without peri-axonemal structures, such as ventricle and nodal cilia. In both humans and mice, MNS1is known to be associated with the motility of embryonic node cilia,[19] whose defect can cause random situs solitus or lateral abnormalities.[17],[19]Mns1-knockout mice also exhibited hydrocephalus, whereas no such abnormalities have been reported in humans.[17] In the respiratory system, MNS1 was previously identified in the ciliary proteome of human bronchial epithelial cells,[16] and a few ODAs were missing in Mns1-deficient tracheal cilia in mice.[17] In our study, MNS1 defect was associated with missing peripheral DMTs (2–4 out of 9) and absent ODAs in humans, which is in agreement with the previous findings of a subtle ODA defect in the axonemes of respiratory epithelial cells in Israeli individuals possessing a founder homozygous nonsense mutation (c.724T>C, p. Arg242*) in MNS1.[19] Importantly, an ODA docking complex protein (CCDC114) has been demonstrated to interact with MNS1 and showed reduced expression when MNS1 was defective.[19] These results suggest that MNS1 is of great importance for the normal localization and assembly of axonemal structures and may play a role in ODA docking during axonemal formation. MNS1 has been demonstrated to self-dimerize in a head-to-tail fashion and is known to have different isoforms.[17] Therefore, we speculate that different isoforms of MNS1 could function with different mechanisms during spermiogenesis and ciliogenesis.
However, in our study and existing literature, MNS1 mutations are only associated with human OAT and lateral abnormalities, but not definite respiratory disorders – the hallmark of primary ciliary dyskinesia (PCD, OMIM#2444). PCD is a heterogeneous disease characterized by recurrent infections of the respiratory system (e.g., bronchiectasis and chronic sinusitis), which is caused by the defective motility of motile cilia.[32] Owing to randomization, situs abnormalities only occur in about half of the patients with PCD and can also be caused by a deficiency in other genes unrelated to PCD.[33],[34] Male infertility due to flagellar defects is not included in the diagnosis of PCD.[32] Further, sperm parameters are not systematically explored in patients with PCD and are often only scarcely described during PCD-related investigations.[35] Leslie et al.[18] recently identified another homozygous MNS1 Amish founder gene variant (c.407_410del; p. Glu136Glyfs*16) to be responsible for laterality defects and male infertility without other features of PCD or ciliopathies. Taken together, MNS1 may not be a definite PCD-related gene, even though it is expressed in respiratory cilia and its function may be dispensable or complemented by other proteins. However, MNS1 is essential for determining left–right asymmetry and flagellar biogenesis, and further investigation is needed to characterize the precise molecular role of MNS1 in cilium and flagellum biogenesis. Moreover, MMAF syndrome is also a specific type of asthenoteratozoospermia, and it has been speculated that MMAF could be a phenotypic variation of classic PCD with seemingly lighter respiratory symptoms.[36] Based on the current evidence of the flagellar morphological similarity between patients with MNS1 mutant and those with MMAF,[37]MNS1 may also be a causative gene of MMAF.
There have been no previously reported ICSI outcomes for patients with MNS1 mutations. In this study, the fertilization rate of the ICSI cycle using the proband's sperm was 80%, suggesting that using the proband's sperm for ICSI could generate viable embryos. The failed transplant may be caused by the maternal factor. However, whether sperm defects caused by MNS1 mutations could affect potential embryonic development or impair ICSI outcomes needs further investigation in a larger population, or a mouse model.
ConclusionOur study demonstrated that a novel homozygous frameshift mutation in MNS1 was responsible for OAT in a human subject. This is the first report on a Chinese OAT proband harboring a MNS1 mutation and the results of his ICSI treatment. Our findings may contribute to the genetic counseling and fertility guidance of patients with male infertility and laterality defects.
Author ContributionsYL performed the functional experiments and wrote the manuscript. WLW analyzed the WES data and helped to draft the manuscript. CFT performed the bioinformatics analysis. LLM and TYH collected the samples. JD carried out the genetic studies. GL provided clinical information. HCN and YQT conceived the study and participated in its design and coordination. All authors read and approved the final manuscript.
Competing InterestsAll authors declare no competing interests.
AcknowledgmentsWe thank the proband in this research and his family members for their consent and support to publish this manuscript. This study was supported by grants from the National Key Science Program S&T Program (2018YFC1004900 to YQT), the National Natural Science Foundation of China (81971447 to YQT), the Science and Technology Major Project of the Ministry of Science and Technology of Hunan Province (2017SK1030 to YQT), and Graduate Research and Innovation Projects of Central South University (2019zzts734 to YL and 2019zzts322 to WLW).
Supplementary Information is linked to the online version of the paper on the Asian Journal of Andrology website.
References
Comments (0)